JNT-517   Click here for help

GtoPdb Ligand ID: 12899

Synonyms: JNT517
Compound class: Synthetic organic
Comment: JNT-517 (Jnana Therapeutics) is an oral, allosteric inhibitor of SCL6A19-mediated phenylalanine reabsorption in the kidney. It is in clinical development for potential to treat phenylketonuria, an inherited metabolic disorder caused by phenylalanine hydroxylase (PAH) deficiency. The chemical structure shown here was revealed during the First Time Disclosures session at the ACS meeting in September 2023, and we picked it up from Drug Hunter. Jnana Therapeutics have a patent that claims small molecule SCL6A19 inhibitors (WO2023122267A2), but this structure doesn't appear in that patent [1].
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 87.9
Molecular weight 418.39
XLogP 1.41
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES C1C[C@H](CN(C1)C(=O)N)N(C2CC2)C(=O)NCC3=CC=C(C=C3F)OC(F)(F)F
Isomeric SMILES NC(=O)N1CCC[C@H](C1)N(C2CC2)C(=O)NCC3=CC=C(OC(F)(F)F)C=C3F
InChI InChI=1S/C18H22F4N4O3/c19-15-8-14(29-18(20,21)22)6-3-11(15)9-24-17(28)26(12-4-5-12)13-2-1-7-25(10-13)16(23)27/h3,6,8,12-13H,1-2,4-5,7,9-10H2,(H2,23,27)(H,24,28)/t13-/m1/s1
InChI Key FNRHWODWSBDOOY-CYBMUJFWSA-N
No information available.
Summary of Clinical Use Click here for help
JNT-517 is in clinical development as a potential first-in-class oral treatment for phenylketonuria (PKU). The FDA granted JNT-517 Rare Pediatric Disease Designation in late 2022.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05781399 First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria Phase 1 Interventional Jnana Therapeutics